Lung cancer
Conditions
Interventions
None listed
Sponsors
Japanese Foundation for Cancer Research
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients aged 18 years or older at the time of surgery who underwent complete resection for clinical stage IA or IB (TNM classification, 7th edition) primary lung cancer (or suspected) between January 1, 2013 and December 31, 2013. 2) Patients with a final pathological diagnosis of primary lung cancer (including small cell lung cancer). 3) Patients who have undergone lobectomy, segmentectomy (up to 4 segments, including subsegmentectomy), or partial resection. 4) Patients who have not been found to have a recurrence of the disease (or death from the disease).
Exclusion criteria
Exclusion criteria: 1) Patients with a history of lung resection (including benign diseases). 2) Patients who have undergone preoperative treatment (drug therapy, radiation therapy, or chemoradiotherapy). 3) Patients who have undergone resection of more than one lobe (lobectomy + partial resection, lobectomy + segmentectomy, bi-lobectomy, pneumonectomy, etc.). 4) Patients who have undergone partial resection or segmentectomy of two or more separate parts of the lung. 5) Patients who have undergone bronchoplasty, vascularplasty, and combined resection of surrounding organs (chest wall, pericardium, etc.). 6) Patients who died within 30 days of surgery or died in hospital within 90 days of surgery. 7) Patients who refused to participate in the study. 8) Patients whom the investigator deems ineligible for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Event-free survival by cause of death,overall survival by patient background factors | — |
Countries
Japan
Contacts
Public ContactMasyauki Nakao
Cancer Institute Hospital, Japanese Foundation for Cancer Research Department of Thoracic Surgical Oncology
Outcome results
None listed